Your email has been successfully added to our mailing list.

×
0.00608272506082712 0.00608272506082712 0.00729927007299276 0.00364963503649627 0.0413625304136253 0.0352798053527979 0.0413625304136253 0.0325790754257907
Stock impact report

Vaccinex up 10% on updated pepinemab data in lung cancer [Seeking Alpha]

VACCINEX INC (VCNX) 
Company Research Source: Seeking Alpha
Healthcare|On the MoveVaccinex up 10% on updated pepinemab data in lung cancerApr. 27, 2020 11:16 AM ETVaccinex, Inc. (VCNX)Douglas W. HouseThinly traded nano cap Vaccinex (+9.8%updated dataCLASSICAL-LungPFE+1.5%OTCPK:MKGAYThe disease control rate (responders + stable cancer) was 81% (n=17/21) in immunotherapy-naïve patients. All responses were partials. Four patients experienced a durable clinical benefit for more than one year.59% (n=17/29) of patients who progressed during or after anti-PD-1/L1 therapy who switched to the combo benefitted (specifics not provided).Development is ongoing.Pepinemab is a humanized monoclonal antibody that blocks the signaling of a protein called SEMA4K thereby promoting the infiltration of immune cells into cancer cells.See all stocks on the move »Now read:Financial Independence Portfolio: Q1 2020 Update » Show less Read more
Impact Snapshot
Event Time:
VCNX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for VCNX alerts
Opt-in for
VCNX alerts

from News Quantified
Opt-in for
VCNX alerts

from News Quantified